ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
82,728.40
-3.98%
S&P 500
5,770.20
0.55%
Dow Jones
42,801.72
0.52%
US Dollar vs Yen
148.045
0.00%
Brent Oil
70.235
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) ニュース

IMRN

Immuron (IMRN)

Immuron Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:IMRN
日付受信時刻ニュースソース見出しコード企業名
2025/03/0720 : 13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2025/03/0522 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2025/03/0520 : 00GlobeNewswire Inc.Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)NASDAQ:IMRNImmuron Ltd
2025/03/0106 : 43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2025/01/1722 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2025/01/1720 : 00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
2025/01/1522 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2025/01/1520 : 00GlobeNewswire Inc.Immuron Announces New Research Collaboration targeting Antimicrobial ResistanceNASDAQ:IMRNImmuron Ltd
2025/01/1422 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2025/01/1420 : 00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Trial UpdateNASDAQ:IMRNImmuron Ltd
2025/01/1021 : 26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2025/01/0821 : 48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/12/1022 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/12/0623 : 17GlobeNewswire Inc.UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:IMRNImmuron Ltd
2024/12/0622 : 35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
2024/12/0322 : 35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
2024/12/0220 : 00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thNASDAQ:IMRNImmuron Ltd
2024/11/2220 : 33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/11/2208 : 33GlobeNewswire Inc.Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNASDAQ:IMRNImmuron Ltd
2024/11/1822 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/11/1420 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/10/2919 : 22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/10/1819 : 06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/10/1621 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/10/1619 : 00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceNASDAQ:IMRNImmuron Ltd
2024/10/1521 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/10/1519 : 00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
2024/10/0820 : 19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/10/0419 : 30GlobeNewswire Inc.NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyNASDAQ:IMRNImmuron Ltd
2024/10/0419 : 20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
COIN
DOGEUSD
Dogecoin
SPI
SP500
S&P 500
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
NASDAQ
NVDA
NVIDIA
CCOM
US30
US 30
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す